Grzegorz Satała

Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A/5-HT2A/5-HT7 and dopamine D2/D3 receptors

Paweł Zajdel, Krzysztof Marciniec, Andrzej Maślankiewicz et al. · European Journal of Medicinal Chemistry · 2012 · 108 citations · Full text

Isoquinoline-sulfonamide Analogs, Medicinal Chemistry, Psychoactive Drug +12

Novel 1<i>H</i>-Pyrrolo[3,2-<i>c</i>]quinoline Based 5-HT₆ Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer’s Disease

Katarzyna Grychowska, Grzegorz Satała, Tomasz Kos et al. · ACS Chemical Neuroscience · 2016 · 81 citations · Full text

Pharmacotherapy, Chemical Biology, Alzheimer ’ +19

Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor—5-HT1A/5-HT2A/5-HT7 and D2/D3/D4—agents: The synthesis and pharmacological evaluation

Paweł Zajdel, Krzysztof Marciniec, Andrzej Maślankiewicz et al. · Bioorganic & Medicinal Chemistry · 2012 · 68 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +11

Synthesis and Evaluation of Antidepressant‐like Activity of Some 4‐Substituted 1‐(2‐methoxyphenyl)Piperazine Derivatives

Anna M. Waszkielewicz, Karolina Pytka, Anna Rapacz et al. · Chemical Biology & Drug Design · 2014 · 59 citations · Full text

Psychotropic Medication, Psychopharmacology, Tail Suspension +18

Exploring protein hotspots by optimized fragment pharmacophores

Dávid Bajusz, Warren S. Wade, Grzegorz Satała et al. · Nature Communications · 2021 · 57 citations · Full text